sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides
暂无分享,去创建一个
Hao Ye | Huixiao Hong | Heng Luo | Hui Wen Ng | Sugunadevi Sakkiah | Donna L. Mendrick | H. Hong | Heng Luo | S. Sakkiah | H. Ng | D. Mendrick | Hao Ye
[1] W R Mayr,et al. Nomenclature for factors of the HLA system, 2004 , 2005, Tissue antigens.
[2] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[3] Yadi Zhou,et al. Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method , 2012, PloS one.
[4] Feixiong Cheng,et al. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science. , 2015, Biomarkers in medicine.
[5] S. A. Marshall,et al. Minimizing the immunogenicity of protein therapeutics. , 2004, Drug discovery today.
[6] Hao Ye,et al. Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data. , 2016, Environment international.
[7] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[8] J. McCluskey,et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.
[9] Woncheol Jang,et al. Permutation test for incomplete paired data with application to cDNA microarray data , 2012, Comput. Stat. Data Anal..
[10] Weida Tong,et al. Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. , 2012, Chemical research in toxicology.
[11] Huixiao Hong,et al. Spec2D: A Structure Elucidation System Based on 1H NMR and H-H COSY Spectra in Organic Chemistry , 2006, J. Chem. Inf. Model..
[12] Leming Shi,et al. Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions. , 2015, Combinatorial chemistry & high throughput screening.
[13] Bin Chen,et al. Assessing Drug Target Association Using Semantic Linked Data , 2012, PLoS Comput. Biol..
[14] M. Leboyer,et al. A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia , 2015, Translational Psychiatry.
[15] Ping Jin,et al. Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling , 2003, Journal of Translational Medicine.
[16] Xinquan Xin,et al. ESSESA: An Expert System for Structure Elucidation from Spectra. Part 3. LNSCS for Chemical Knowledge Representation. , 1992 .
[17] S. Kondo,et al. Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs. , 2015, Tissue antigens.
[18] Weida Tong,et al. Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..
[19] Huixiao Hong,et al. ESSESA: an expert system for elucidation of structures from spectra. 1. Knowledge base of infrared spectra and analysis and interpretation programs , 1990, J. Chem. Inf. Comput. Sci..
[20] Nan Hu,et al. Decision Forest Analysis of 61 Single Nucleotide Polymorphisms in a Case-Control Study of Esophageal Cancer; a novel method , 2005, BMC Bioinformatics.
[21] Huixiao Hong,et al. ESSESA: An expert system for structure elucidation from spectra. 3. LNSCS for chemical knowledge representation , 1992, J. Chem. Inf. Comput. Sci..
[22] Weida Tong,et al. Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets. , 2015, Chemical research in toxicology.
[23] H. Fang,et al. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor , 2003, SAR and QSAR in environmental research.
[24] Gonzalo Mateos,et al. Modeling and Optimization for Big Data Analytics: (Statistical) learning tools for our era of data deluge , 2014, IEEE Signal Processing Magazine.
[25] James Robinson,et al. The IMGT/HLA database , 2008, Nucleic Acids Res..
[26] Weida Tong,et al. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[27] Weida Tong,et al. Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds. , 2015, Chemical research in toxicology.
[28] Weida Tong,et al. The Accurate Prediction of Protein Family from Amino Acid Sequence by Measuring Features of Sequence Fragments , 2009, J. Comput. Biol..
[29] Weida Tong,et al. Consensus analysis of multiple classifiers using non-repetitive variables: Diagnostic application to microarray gene expression data , 2007, Comput. Biol. Chem..
[30] S. Demaria,et al. Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[31] Weida Tong,et al. Multiclass Decision Forest--a novel pattern recognition method for multiclass classification in microarray data analysis. , 2004, DNA and cell biology.
[32] Marij J P Welters,et al. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy. , 2006, Advanced drug delivery reviews.
[33] Pascal Poncet,et al. MHC class II‐dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation , 1999, Journal of leukocyte biology.
[34] Morten Nielsen,et al. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.
[35] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[36] H Hong,et al. An in silico ensemble method for lead discovery: decision forest , 2005, SAR and QSAR in environmental research.
[37] G. Chelvanayagam. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities , 1996, Immunogenetics.
[38] Sneh Lata,et al. MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes , 2009, BMC Research Notes.
[39] Jie Li,et al. Prediction of Polypharmacological Profiles of Drugs by the Integration of Chemical, Side Effect, and Therapeutic Space , 2013, J. Chem. Inf. Model..
[40] John Trowsdale,et al. The MHC, disease and selection. , 2011, Immunology letters.
[41] Mohd Saberi Mohamad,et al. A Review on Missing Value Imputation Algorithms for Microarray Gene Expression Data , 2014 .
[42] Bettina Wachter,et al. Cheetah Paradigm Revisited: MHC Diversity in the World's Largest Free-Ranging Population , 2010, Molecular biology and evolution.
[43] Weida Tong,et al. Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes , 2013, BMC Bioinformatics.
[44] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[45] Jean-Philippe Vert,et al. Efficient peptide-MHC-I binding prediction for alleles with few known binders , 2008, Bioinform..
[46] O. Lund,et al. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ , 2013, Immunogenetics.
[47] James McCluskey,et al. Human leukocyte antigen-associated drug hypersensitivity. , 2013, Current opinion in immunology.
[48] Leonardo Franco,et al. Missing data imputation using statistical and machine learning methods in a real breast cancer problem , 2010, Artif. Intell. Medicine.
[49] Mohammad Tuhin Ali,et al. A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus , 2015, Interdisciplinary Sciences: Computational Life Sciences.
[50] Z. Modrušan,et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing , 2014, Nature.
[51] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[52] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[53] Nopporn Kaiyawet,et al. Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's Disease , 2015, PloS one.
[54] W. Potts,et al. The Nature of Selection on the Major Histocompatibility Complex. , 2017, Critical reviews in immunology.
[55] Jie Li,et al. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug–target interactions and drug repositioning , 2016, Briefings Bioinform..
[56] Peter Bühlmann,et al. MissForest - non-parametric missing value imputation for mixed-type data , 2011, Bioinform..
[57] E. Sim,et al. Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.
[58] T. Ohta,et al. Population Biology of Antigen Presentation by MHC Class I Molecules , 1996, Science.
[59] Morten Nielsen,et al. NNAlign: A Web-Based Prediction Method Allowing Non-Expert End-User Discovery of Sequence Motifs in Quantitative Peptide Data , 2011, PloS one.
[60] Morten Nielsen,et al. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers , 2008, Bioinform..
[61] Morten Nielsen,et al. Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..
[62] Weida Tong,et al. Using Decision Forest to Classify Prostate Cancer Samples on the Basis of SELDI-TOF MS Data: Assessing Chance Correlation and Prediction Confidence , 2004, Environmental health perspectives.
[63] Alessandro Sette,et al. The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..
[64] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[65] Huixiao Hong,et al. ESSESA: An Expert System for Structure Elucidation from Spectra. 5. Substructure Constraints from Analysis of First-Order 1H-NMR Spectra , 1994, J. Chem. Inf. Comput. Sci..
[66] Hiroshi Mamitsuka,et al. Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools , 2011, Briefings Bioinform..
[67] J. Villadangos,et al. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo , 2007, Nature Reviews Immunology.
[68] Jie Shen,et al. Adverse Drug Events: Database Construction and in Silico Prediction , 2013, J. Chem. Inf. Model..
[69] Thomas Boehm,et al. MHC peptides and the sensory evaluation of genotype , 2006, Trends in Neurosciences.
[70] Zhongming Zhao,et al. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes , 2016, Briefings Bioinform..
[71] William W Kwok,et al. HLA class II peptide-binding and autoimmunity. , 2002, Tissue antigens.
[72] Weida Tong,et al. Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis , 2015, BMC Bioinformatics.
[73] Ronald E. Bontrop,et al. Immunogenetics , 2005, Genes and Immunity.
[74] Jennifer L. Johnson,et al. Transcriptome Analysis in Domesticated Species: Challenges and Strategies , 2015, Bioinformatics and biology insights.
[75] Darren R. Flower,et al. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores , 2006, BMC Bioinformatics.
[76] Weida Tong,et al. Decision Forest: Combining the Predictions of Multiple Independent Decision Tree Models , 2003, J. Chem. Inf. Comput. Sci..
[77] Weida Tong,et al. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. , 2001, Environmental health perspectives.
[78] Jie Li,et al. Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology , 2014, Scientific Reports.
[79] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[80] Huixiao Hong,et al. Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure. , 2015, Chemical research in toxicology.
[81] Lei Xu,et al. The EDKB: an established knowledge base for endocrine disrupting chemicals , 2010, BMC Bioinformatics.
[82] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[83] Xinquan Xin,et al. ESSESA, an expert system for structure elucidation from spectral analysis , 1992 .
[84] Hong Yan,et al. Missing value imputation for gene expression data: computational techniques to recover missing data from available information , 2011, Briefings Bioinform..
[85] Huixiao Hong,et al. ESSESA: An Expert System for Structure Elucidation from Spectra. 4. Canonical Representation of Structures , 1994, J. Chem. Inf. Comput. Sci..
[86] Jie Shen,et al. Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs). , 2013, Molecular bioSystems.
[87] Weida Tong,et al. EADB: an estrogenic activity database for assessing potential endocrine activity. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[88] Channa K. Hattotuwagama,et al. AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data , 2005, Immunome research.
[89] Weida Tong,et al. Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands , 2014, International journal of environmental research and public health.
[90] M. Torres,et al. Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.
[91] Paul M. Allen,et al. Specificity of T-cell alloreactivity , 2007, Nature Reviews Immunology.
[92] Weida Tong,et al. Machine Learning Methods for Predicting HLA–Peptide Binding Activity , 2015, Bioinformatics and biology insights.
[93] Weida Tong,et al. Assessing QSAR Limitations - A Regulatory Perspective , 2005 .